This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

The Value of Preoperative Dynamic Lymphscintigraphy and Ultrasoundscanning, Eventually With FNA, for Identification of Malignant Sentinel Node(s) in Patients With Melanoma

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified August 2012 by Trine-Lise Lambine, Rigshospitalet, Denmark.
Recruitment status was:  Enrolling by invitation
Information provided by (Responsible Party):
Trine-Lise Lambine, Rigshospitalet, Denmark Identifier:
First received: August 30, 2012
Last updated: August 31, 2012
Last verified: August 2012
The goal with this study is to evaluate the value of dynamic lymphscintigraphy and ultrasoundscanning preoperative in patients with melanomas.

Condition Intervention
Melanoma Procedure: FNA (fine needle aspiration)

Study Type: Interventional

Resource links provided by NLM:

Further study details as provided by Trine-Lise Lambine, Rigshospitalet, Denmark:

Study Start Date: September 2012
Arms Assigned Interventions
Experimental: ultrasound, dynamic lymphscintigraphy Procedure: FNA (fine needle aspiration)


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

Histologically verified melanomas, at least 1 mm thickness, or thinner melanomas with ulceration and/or Clarks level IV-V and/or mitoserate at least 1/mm2.

Exclusion Criteria:

Other malignant illness Known local, regional or non-regional metastasis on the time of diagnonsis Comorbidity which contraindicate lymphnoderemoval Age less than 18 yrs

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01677975

Ultrasounddepartment 4123, Rigshospitalet
Blegdamsvej 9, København Ø, Denmark, 2100
Sponsors and Collaborators
Rigshospitalet, Denmark
  More Information

Responsible Party: Trine-Lise Lambine, afdelingslæge, Rigshospitalet, Denmark Identifier: NCT01677975     History of Changes
Other Study ID Numbers: Ultrasound in melanomas
Study First Received: August 30, 2012
Last Updated: August 31, 2012

Additional relevant MeSH terms:
Neuroendocrine Tumors
Neuroectodermal Tumors
Neoplasms, Germ Cell and Embryonal
Neoplasms by Histologic Type
Neoplasms, Nerve Tissue
Nevi and Melanomas processed this record on August 23, 2017